Literature DB >> 19554253

[Diagnosis and treatment of femural neck fractures from the beginning to operative treatment: a historical overview].

M Lucke1, U Stöckle, C Lucke.   

Abstract

Operative stabilisation of femural neck fractures is a routine procedure nowadays and is usually performed without delay. Treatment by osteosynthesis or endoprosthesis allows immediate mobilisation with at least partial weight bearing.Immobilisation for months, associated with high mortality as practiced in former times, is nearly forgotten. We present a review on 430 years of diagnosis and treatment of these fractures since the first description by Ambroise Paré. In fact, it took 150 years to recognise the different locations of various hip fractures; at the time, fractures close to the caput were felt to have no chance of healing. Impacted fractures of the femural neck were first described 250 years after the first publication by A. Paré.This article also presents an overview on the development of various treatments to stabilise hip fractures: closed reduction and repositioning by internal rotation of the external rotated leg, positioning of the leg on the double inclined splint, different types of extension treatment and finally early operative procedures, when asepsis was established and fractures could be imaged by x-rays.

Entities:  

Mesh:

Year:  2009        PMID: 19554253     DOI: 10.1007/s00391-008-0016-2

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  3 in total

1.  The first 32 years of total hip arthroplasty. One surgeon's perspective.

Authors:  W H Harris
Journal:  Clin Orthop Relat Res       Date:  1992-01       Impact factor: 4.176

2.  Fractures of the femoral ncek: a brief review.

Authors:  E T Preston
Journal:  Rev Surg       Date:  1972 May-Jun

3.  The classic. The treatment of fractures of the neck of the femur by immediate reduction and permanent fixation. By Nicholas Senn. 1889.

Authors: 
Journal:  Clin Orthop Relat Res       Date:  1987-05       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.